发明名称 |
Compositions and methods for treatment of ear disorders |
摘要 |
The present invention relates to pharmaceutical compositions useful for topical, non-invasive delivery of an oligonucleotide to the ear and to methods for the treatment of an ear disorder, including hearing loss arising from chemical-induced ototoxicity, acoustic trauma and presbycusis; and microbial infections. The method comprises topically administering to the ear of a subject in need thereof a pharmaceutical composition comprising an inhibitory oligonucleotide, a permeability enhancer and a pharmaceutically acceptable carrier, wherein the oligonucleotide reduces or inhibits expression of a gene associated with the ear disorder in the subject. |
申请公布号 |
US9089591(B2) |
申请公布日期 |
2015.07.28 |
申请号 |
US201313867837 |
申请日期 |
2013.04.22 |
申请人 |
QUARK PHARMACEUTICALS, INC. |
发明人 |
Alpert Evgenia;Spivak Igor;Bar-Ilan Amir |
分类号 |
A61K48/00;C07H21/02;C07H21/04;A61K31/713;A61K9/00;C12N15/113 |
主分类号 |
A61K48/00 |
代理机构 |
Cooper & Dunham LLP |
代理人 |
White John P.;Cooper & Dunham LLP |
主权项 |
1. A method of treating a subject suffering from or at risk of an ear disorder, comprising topically administering to the canal of the subject's ear an otic pharmaceutical composition comprising a therapeutically effective amount of at least one oligonucleotide compound, glycerol at a final concentration of about 0.1-30% v/v of the composition, and a pharmaceutically acceptable excipient or carrier, or mixtures thereof, thereby delivering said oligonucleotide compound to the inner ear and/or middle ear of a subject in an amount sufficient for down-regulating expression of a target gene associated with the disorder in the inner ear and/or middle ear of the subject. |
地址 |
Fremont CA US |